Auven Therapeutics is a private equity firm pursuing an innovative life science investment strategy. Although it utilizes a fund structure, it also has an internal drug development company that allows it to more effectively manage drug development and grow the value of its therapeutic assets.
View Top Employees from Auven Therapeutics| Website | http://www.auventx.com |
| Revenue | $6.7 million |
| Employees | 10 (9 on RocketReach) |
| Founded | 2005 |
| Address | 475 NE 1st St Ste A, Delray Beach, Florida 33483, US |
| Phone | (954) 908-2360 |
| Fax | (908) 279-0651 |
| Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services |
| Competitors | Boehringer Ingelheim Venture Fund, Cellectar Biosciences, Inc., Zumutor Biologics Inc. |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Auven Therapeutics employee's phone or email?
Auven Therapeutics Questions
The Auven Therapeutics annual revenue was $6.7 million in 2024.
Jim Cooper is the Head of IT of Auven Therapeutics.
9 people are employed at Auven Therapeutics.
Auven Therapeutics is based in Delray Beach, Florida.
The NAICS codes for Auven Therapeutics are [32541, 3254, 325, 32].
The SIC codes for Auven Therapeutics are [28, 283].
Top Auven Therapeutics Employees
-
5+5+
-
34
-
33
Related Companies
